Milestone prediction for time-to-event endpoint monitoring in clinical trials

被引:1
|
作者
Ou, Fang-Shu [1 ]
Heller, Martin
Shi, Qian [1 ]
机构
[1] Mayo Clin, Dept Hlth Sci Res, Canc Ctr, Rochester, MN USA
基金
美国国家卫生研究院;
关键词
clinical trial; density forecast combination; event modeling; model stacking; prediction synthesis; trial monitoring; FLUOROURACIL; RECRUITMENT; OXALIPLATIN; LEUCOVORIN; ENROLLMENT; STACKING; COUNTS;
D O I
10.1002/pst.1934
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Predicting the times of milestone events, ie, interim and final analyses in clinical trials, helps resource planning. This manuscript presents and compares several easily implemented methods for predicting when a milestone event is achieved. We show that it is beneficial to combine the predictions from different models to craft a better predictor through prediction synthesis. Furthermore, a Bayesian approach provides a better measure of the uncertainty involved in prediction of milestone events. We compare the methods through two simulations where the model has been correctly specified and where the models are a mixture of three incorrectly specified model classes. We then apply the methods on two real clinical trial data, North Central Cancer Treatment Group (NCCTG) N0147 and N9841. In summary, the Bayesian prediction synthesis methods automatically perform well even when the data collection is far from homogeneous. An R shiny app is under development to carry out the prediction in a user-friendly fashion.
引用
收藏
页码:433 / 446
页数:14
相关论文
共 50 条
  • [21] Projection of power and events in clinical trials with a time-to-event outcome
    Royston, Patrick
    Barthel, Friederike M-S
    [J]. STATA JOURNAL, 2010, 10 (03): : 386 - 394
  • [22] Analysis of a composite endpoint with longitudinal and time-to-event data
    Tseng, Chi-hong
    Wong, Weng Kee
    [J]. STATISTICS IN MEDICINE, 2011, 30 (09) : 1018 - 1027
  • [23] Sample size calculation for randomized selection trials with a time-to-event endpoint and a margin of practical equivalence
    Dehbi, Hakim-Moulay
    Embleton-Thirsk, Andrew
    McCaw, Zachary Ryan
    [J]. STATISTICS IN MEDICINE, 2022, 41 (20) : 4022 - 4033
  • [24] Assessment of proportional hazard assumption in aggregate data: a systematic review on statistical methodology in clinical trials using time-to-event endpoint
    Eliana Rulli
    Francesca Ghilotti
    Elena Biagioli
    Luca Porcu
    Mirko Marabese
    Maurizio D’Incalci
    Rino Bellocco
    Valter Torri
    [J]. British Journal of Cancer, 2018, 119 : 1456 - 1463
  • [25] Assessment of proportional hazard assumption in aggregate data: a systematic review on statistical methodology in clinical trials using time-to-event endpoint
    Rulli, Eliana
    Ghilotti, Francesca
    Biagioli, Elena
    Porcu, Luca
    Marabese, Mirko
    D'Incalci, Maurizio
    Bellocco, Rino
    Torri, Valter
    [J]. BRITISH JOURNAL OF CANCER, 2018, 119 (12) : 1456 - 1463
  • [26] A multistate platform model for time-to-event endpoints in oncology clinical trials
    Lin, Chih-Wei
    Nagase, Mario
    Doshi, Sameer
    Dutta, Sandeep
    [J]. CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2024, 13 (01): : 154 - 167
  • [27] Power considerations for clinical trials using multivariate time-to-event data
    Hughes, MD
    [J]. STATISTICS IN MEDICINE, 1997, 16 (08) : 865 - 882
  • [28] Sizing clinical trials when comparing bivariate time-to-event outcomes
    Sugimoto, Tomoyuki
    Hamasaki, Toshimitsu
    Evans, Scott R.
    Sozu, Takashi
    [J]. STATISTICS IN MEDICINE, 2017, 36 (09) : 1363 - 1382
  • [29] A hybrid approach to predicting events in clinical trials with time-to-event outcomes
    Fang, Liang
    Su, Zheng
    [J]. CONTEMPORARY CLINICAL TRIALS, 2011, 32 (05) : 755 - 759
  • [30] Heterogeneous treatment effects in stratified clinical trials with time-to-event endpoints
    Beisel, Christina
    Benner, Axel
    Kunz, Christina
    Kopp-Schneider, Annette
    [J]. BIOMETRICAL JOURNAL, 2017, 59 (03) : 511 - 530